Skip to Royal Victorian Eye and Ear Hospital Primary Content

Skip to Navigation

Safety Monitoring and Reporting (from 23 October 2019)

The Eye and Ear has adopted the following guidelines from 1 April 2019

  1. NHMRC Guidance: Safety monitoring and reporting in clinical trials involving therapeutic goods (NHMRC; November 2016)
  2. NHMRC Guidance: Risk-based management and monitoring of Clinical Trials involving Therapeutic Goods (NHMRC; 2018)
  3. NHMRC Guidance Reporting of Serious Breaches of Good Clinical Practice (GDP) or the Protocol for Trials Involving Therapeutic Goods (NHMRC; 2018)
  4. NHMRC Guidance Data Safety Monitoring Boards (DSMBs) (NHMRC; 2018)

All guidelines are available from the NHMRC website.

The Eye and Ear Monitoring and Safety Reporting of Research Projects Procedures (including a summary table) have been reviewed and updated and apply from 23 October 2019. 


Risk Assessment

The Eye and Ear requires that all research projects are monitored according to a risk-based approach.

Risk assessment can be conducted using any model.  Suggestions include:

Monitoring and Safety Reporting

Refer to the sections below regarding monitoring and safety reporting requirements:

Last updated 23 October 2019